City
Epaper

VP calls for research on zoonotic diseases

By IANS | Updated: July 2, 2021 16:16 IST

Hyderabad, July 2 Vice President M. Venkaiah Naidu on Friday underlined the need for research to predict zoonotic ...

Open in App

Hyderabad, July 2 Vice President M. Venkaiah Naidu on Friday underlined the need for research to predict zoonotic diseases better.

Alluding to zoonotic diseases like Covid-19, he urged the researchers and zoos to utilize their resources and expertise optimally to predict emerging infectious diseases from animals to humans.

He visited Laboratory for the Conservation of Endangered Species (LaCONES) at CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad on Friday. The Vice President interacted with the wildlife scientists and saw the main facilities for wildlife conservation at LaCONES. This included the National Wildlife Genetic Resource Bank and the Assisted Reproduction Lab.

He also released a book on 'Introduction to Genetic Resource Banks for Wildlife Conservation' authored by LaCONES and Central Zoo Authority.

Venkaiah Naidu emphasized on the importance of studying wildlife for conserving endangered species and to also understand and predict zoonotic diseases better. "Research institutes such as LaCONES-CCMB and zoos have to work together. Zoos across the country can avail the different modern biology tools for studying diseases in wildlife, preserve their genetic material, avail assisted reproductive technologies. They should also be a partner in research to understand reproductive anatomy and physiology in wildlife," he said.

Recently Central Zoo Authority formed a consortium of six zoos from different parts of India and LaCONES-CCMB. "Central Zoo Authority has been instrumental in bringing zoos together with a research institute like ours. We want this consortium to set an example of how zoos and a wildlife research institute like LaCONES can work cohesively towards shared goals. The National Wildlife Genetic Resource Bank at LaCONES can become a storehouse of biological samples from all zoos in India. These samples can then be used for artificial insemination, creating sperms and oocytes through modern biotechnological tools, and help revive the endangered animals," said Dr Karthikeyan Vasudevan, Scientist-in-charge at LaCONES-CCMB.

Vinay Nandicoori, Director, CSIR-CCMB observed that in the current scene of climate change and a pandemic, it is necessary and timely that active collaborations happen between molecular biologists, ecologists and zoos. "Many countries have shown examples of how this can be done impactfully. And LaCONES-CCMB has demonstrated its capabilities over the last decade. It is time for Indian zoos to take advantage of our tools and expertise," he said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: National wildlife genetic resource bankCentral zoo authorityVinay nandicooriindiaHyderabadNagarHyderIndiUk-indiaRepublic of indiaIndia indiaGia india
Open in App

Related Stories

NationalHyderabad: Over 200 Kg Artificially Ripened Mangoes With Chemicals Seized During Police Raid, Trader Arrested

NationalTelangana Shocker: Woman, Two Children Found Dead After Husband’s Second Marriage in Hyderabad

PunePune Gets Bullet Train Connectivity: Mumbai Travel Time to Drop to 48 Minutes, Hyderabad in Just 2 Hours

NationalHyderabad Horror: Missing Woman Found Dead in Her Jawaharnagar Residence; Daughter Confesses to Killing Mother

InternationalIranian President Calls for Constructive Role of Brics to Halt West Asia Conflict During Talks With PM Modi

Health Realted Stories

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns